1200 Participants Needed

Jumpstart Guide for Dementia Care Planning

(PICSI-M Trial)

Recruiting at 2 trial locations
EN
JM
JW
Overseen ByJessica Walsh
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to help clinicians have better conversations to address patients' goals for their healthcare. To do this, we created a simple, short guide called the "Jumpstart Guide." The goal of this research study is to show that using this kind of guide is possible and can be helpful for patients and their families. Patients' clinicians may receive a Jumpstart Guide before the patient's clinic visit. Researchers will compare patients whose clinician received a Jumpstart Guide to patients whose clinician did not receive a guide to see if more patients in the Jumpstart Guide group had conversations about the patient's goals for their healthcare. Patients and their family members will also be asked to complete surveys after the visit with their clinician.

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on improving communication rather than changing medication regimens.

What data supports the effectiveness of the Jumpstart Guide treatment for dementia care planning?

The research highlights that non-drug approaches, like the Jumpstart Guide, which focus on promoting independence, are effective and preferred by people with dementia and their caregivers, although they are not always used regularly.12345

How does the Jumpstart Guide for Dementia Care Planning treatment differ from other treatments for dementia?

The Jumpstart Guide for Dementia Care Planning is unique because it focuses on providing tailored support recommendations for caregivers through an online tool, rather than directly treating the dementia itself. This approach helps caregivers find the best support without the trial and error typically involved in managing dementia care.678910

Research Team

EK

Erin Kross, MD

Principal Investigator

University of Washington

Eligibility Criteria

This trial is for patients aged 55+ with memory issues and chronic conditions like cancer, heart failure, or diabetes. It's also for their caregivers who are involved in their care. Participants must speak English and be treated at a UW Medicine clinic. Clinicians from UW Medicine caring for these patients can join too.

Inclusion Criteria

I am 55 years old or older.
(Interviews) Identified as clinician of record for an enrolled patient in the trial and received a Jumpstart guide
If have ADRD and not followed by a primary care clinician at UW Medicine but are followed by a subspecialist, must also have an ICD-10 code for one or more of seven chronic conditions used by the Dartmouth Atlas, relevant for the specialist they see, to ensure that goals-of care discussions are applicable for these specialists in the care of the enrolled patient
See 7 more

Exclusion Criteria

I am unable to give consent and do not have someone to do it for me.
I do not have physical or mental limitations that prevent me from completing study tasks.
Non-English speaking
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Randomization and Intervention Preparation

Patients are randomized to either the Jumpstart intervention or usual care. For those in the intervention arm, a Jumpstart Guide is created using EHR data.

1 week

Intervention Delivery

Jumpstart Guides are delivered to clinicians 1-2 days before the patient's target visit to facilitate goals-of-care discussions.

1-2 days

Survey Follow-up

Patients and family members complete surveys at 1, 3, and 12 months after the target visit to assess outcomes such as palliative care needs and psychological symptoms.

12 months

Qualitative Interviews

At the end of the follow-up period, intervention patients and family members are invited to participate in interviews to evaluate the intervention.

20-30 minutes per interview

Treatment Details

Interventions

  • Jumpstart Guide
Trial Overview Researchers are testing the 'Jumpstart Guide' to see if it helps clinicians discuss healthcare goals more effectively with patients having memory problems and their families. They'll compare outcomes between those using the guide and those not to measure its impact on communication.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Jumpstart GuideExperimental Treatment1 Intervention
The Jumpstart Guide is developed using automated methods. It summarizes the presence/absence of POLST, advance directives and DPOA documentation. The Jumpstart Guide also provides tips for conducting discussion about goals of care.
Group II: Usual CareActive Control1 Intervention
Clinicians of patients in the Usual Care arm will not receive a Jumpstart Guide.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The STOPP/START toolkit was effectively used to review and reduce inappropriate prescriptions among 86 older psychiatric in-patients with dementia, leading to a 7% reduction in comorbidities and an 8% decrease in the number of prescriptions.
Commonly prescribed inappropriate medications included benzodiazepines, antipsychotics, and opiates, while statins, calcium, and vitamin D supplements were often unprescribed, highlighting the need for better medication management in this population.
Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia.Aziz, VM., Hill, N., Kumar, S.[2020]
The guidelines for managing dementia in community-dwelling patients were tested by 17 general practitioners on 119 patients, highlighting the importance of addressing psychosocial issues alongside medical care.
About 50% of the patients benefited from the guidelines, indicating that they are a useful resource for general practitioners in improving dementia care.
The management of dementia in general practice. A field test of guidelines.Bridges-Webb, C., Wolk, J., Britt, H., et al.[2007]
The article presents a good practice guide for prescribing anti-dementia medications, created collaboratively by a lead nurse and a clinical pharmacist, ensuring a comprehensive approach to treatment.
This guide consolidates current evidence into a concise format, aiming to assist healthcare practitioners in making informed prescribing decisions for dementia care.
A guide to prescribing anti-dementia medication.Kennedy, S., Sud, D.[2016]

References

Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia. [2020]
The management of dementia in general practice. A field test of guidelines. [2007]
A guide to prescribing anti-dementia medication. [2016]
Agents of change: establishing quality improvement collaboratives to improve adherence to Australian clinical guidelines for dementia care. [2019]
Dissemination and implementation research in dementia care: a systematic scoping review and evidence map. [2022]
Sexuality and Dementia: a guide for all staff working with people with dementia Carole Archibald Sexuality and Dementia: a guide for all staff working with people with dementia Second The Dementia Services Development Centre Stirling University 49 £12.00 1 85769 1865 1857691865 [Formula: see text]. [2019]
Care to Plan: An Online Tool That Offers Tailored Support to Dementia Caregivers. [2022]
Listen, Talk, Connect: Communicating with People Living with Dementia Listen, Talk, Connect: Communicating with People Living with Dementia 68pp Care UK [Formula: see text]. [2019]
Cards on the table. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Cross-cultural comparison of the perceptions and experiences of dementia care mapping "mappers" in the United States and the United Kingdom. [2016]